Total medical devices industry deals worth $29.3bn were announced globally for November 2022, with Johnson & Johnson’s $16.6bn acquisition deal with Abiomed being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 419.5% over the previous month of $5.63bn and a rise of 149.2% when compared with the last 12-month average of $11.74bn.
In terms of number of deals, the sector saw a drop of 32.04% with 140 deals in November 2022 when compared to the last 12-month average of 206 deals.
In value terms, North America led the activity with deals worth $28.91bn in November 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical Devices industry deals in November 2022: Top deals
The top five deals accounted for 97.6% of the overall value during November 2022.
The combined value of the top five deals stood at $28.56bn, against the overall value of $29.3bn recorded for the month.
The top five medical devices industry deals of November 2022 tracked by GlobalData were:
1) Johnson & Johnson’s $16.6bn acquisition deal with Abiomed
2) The $8.9bn acquisition of Summit Health by VillageMD
3) WerfenLife’s $2bn acquisition deal with Immucor
4) The $615m acquisition of Apollo Endosurgery by Boston Scientific
5) Arsenal Capital Partners’s $449m private equity deal for 18% stake in Certara
